Category Archives: Neurotechnology

DUBLIN, Sept. 6, 2022 /PRNewswire/ -- Tri-anim Health Services, a specialty distributor of respiratory, anesthesia and critical care products and therapies, announced today that it has entered into an exclusive relationship to represent and distribute the BrainScope device in hospital Emergency Departments. This innovative point of caredecision support tool is used to objectively assess mild head injured patients for intracranial hemorrhage and concussion at point of care in 20 minutes or less.

BrainScope is an FDA-cleared, handheld Class II medical device that uses artificial intelligence derived algorithms to identify distinctive profiles of structural brain injury and concussion. The solution consists of the BrainScope handheld decision support tool, as well as the BrainScope single-use disposable electrode headset for use with the device.

Tom Metcalf, President of Tri-anim Health Services, said, "This exclusive agreement supports Tri-anim's mission to be the best partner to those who save and improve patients' lives. We are thrilled to bring the breakthrough BrainScope technology to our Emergency Department customers to help them quickly and effectively assess risk of intracranial bleeding in patients with mild head injuries helping to reduce unneeded CT scans, objectively assess concussions, and improve patient experience and satisfaction."

"This partnership with Tri-anim Health Services brings BrainScope to immediate commercial scale. It is a perfect fit for us as Tri-anim's national sales team is already focused on providing innovative solutions to Emergency Departments," said Susan Hertzberg, CEO of BrainScope. Hertzberg added, "America's Emergency Departments are moving beyond COVID care and the demand for BrainScope is rapidly growing to fill a major assessment gap that exists for the nearly 5 million people that present with mild head injuries each year. Up until now, clinicians have had just one tool, the CT scan. With BrainScope they can more confidently rule out those patients that do not need a CT scan while also objectively assess concussion. We are excited to have the commercial reach that Tri-anim provides."

The BrainScope solution has been highly clinically validated with 10+ years of development, 8 successfully executed research contracts funded by the U.S. Department of Defense, and 33 peer-reviewed publications. When integrated into clinical decision making, experience has demonstrated an average 46% reduction in unnecessary CT utilization, a 40% reduction in patient Emergency Department length of stay, and improved patient experience and satisfaction.

"BrainScope helps answer key clinician and patient questionswhether the patient has suffered a brain bleed or concussion, and whether they are ready to resume normal activities. The technological change that BrainScope brings has immediate benefits to both the patient and the Emergency Department," said Dr. Diku Mandavia, Chief Medical Officer at BrainScope.

Attila Morgan, Eastern Area Vice President of Sales for Tri-anim Health Services added,"BrainScope easily fits into the Emergency Department current workflow for mild head injuries. The device can be operated by non-nursing staff and assessments take less than 20 minutes from start to finish. By avoiding unnecessary CT scans, BrainScope's assessment can help Emergency Departments save significant time and hospital resources."

About Tri-anim Health Services

Tri-anim Health Services provides innovative respiratory, anesthesia and critical care products and therapies to hospitals, health systems and other patient care facilities nationwide. As a leader in healthcare excellence for over 45 years, Tri-anim offers targeted solutions, value-oriented programs, clinical expertise, and in-service training to help provide effective and efficient patient care. For more information, visitwww.tri-anim.com.

About BrainScope

BrainScope is a medical neurotechnology company that is improving brain health by providing objective, diagnostic insights that enable better patient care. BrainScope is leading the way in the rapid and objective assessment of brain-related conditions, starting with mild traumatic brain injury (mTBI), utilizing multiple integrated assessment capabilities, artificial intelligence (AI), and digitization. The Company's technology supports the American College of Emergency Physicians (ACEP) Choosing Wisely campaign to avoid CT scans of the head in Emergency Department patients with minor head injury. BrainScope's innovative neurotechnology platform uses EEG-based, AI-derived algorithms empowering physicians to quickly make accurate head injury assessments, addressing the full spectrum of traumatic brain injuries from structural (brain bleed) to functional (concussion) injuries, providing for the first time a full picture of the injury, and doing so in less time and without radiation. For more information, please visit http://www.brainscope.com.

Media Contact:

Beth Scott, Director of Marketing Communications: 614.760.5000 Beth.Scott@sarnova.com

Cision

View original content:https://www.prnewswire.com/news-releases/tri-anim-health-services-announces-exclusive-relationship-to-distribute-brainscopes-breakthrough-technology-for-mild-head-injury-including-concussion-into-emergency-departments-301618276.html

SOURCE Tri-anim Health Services

See the rest here:

Tri-anim Health Services announces exclusive relationship to distribute BrainScope's breakthrough technology for mild head injury including...

TORONTO--(BUSINESS WIRE)-- Myndlift, a health technology company that offers digital mental health programs using the Muse leading consumer EEG technology platform, recently completed a retrospective study using real-world data that offers preliminary efficacy of remote neurofeedback therapy (NFT) on improved mental health outcomes from 593 participants. Little is currently known regarding the effectiveness of remote NFT systems in supporting disorders such as attention-deficit/hyperactivity disorder (ADHD), anxiety, and depression. With this nascent research and continued validation of Myndlifts combination of traditional neurofeedback, CBT tools, and coaching Myndlift hopes to improve access to mental health tools that can remotely support the general focus and wellbeing of patients with these disorders as a low-cost alternative to clinic-based EEG.

Study participants engaged in remote brain training sessions via Myndlifts mobile app utilizing Muses EEG technology to measure their brain activity and complete pre-and post intervention in-app assessments throughout the course of the study. Improvement was measured from self-reported assessments that included validated symptom questionnaires, a cognitive test of attention and executive functioning (ie, continuous performance task), and resting electroencephalography (EEG) markers. Preliminary findings suggest reduced symptom severity from pre- to post-assessment for general psychological health, ADHD, anxiety, and depression, as well as adjusted resting EEG neural markers for individuals with symptoms of ADHD. The full paper was funded by McGill University and published in JMIR Publications in July 2022.

As the digital health space continues to grow thanks to advances in health technology, Muse will continue supporting developers and SDK partners by prioritizing efforts that allow them to leverage their EEG technology in the development of systems that will support the overall health and wellness of patients. The partnership with Myndlift is an indication of the type of applications and subsequent positive impacts that can result when the right wellness and health partnerships and the best quality resources and technology are connected.

There are ample benefits of accessing clinical-grade technology like EEG for accurate and personalized metrics of brain activity which is why the work Muse is doing to make this technology more widely accessible is so important, said Dr. Walter Greenleaf, Stanford Neuroscientist, Digital Medicine expert, and Interaxon Chief Scientific Officer. By continuing to identify ways to support SDK partners like Myndlift in their development of such applications of these innovative technologies, we all work together to push the health tech space forward and develop more accessible and affordable health and wellness solutions.

Improving Access to Clinical Mental Health Treatment with EEG Technology

Neurofeedback training is currently used to support a range of mental health disorders, though there are several barriers to entry that may prevent patients from receiving quality neurofeedback therapeutics. Typically, EEG (electroencephalography) systems are expensive and are usually only accessible in clinical settings. Traditional neurofeedback training programs can range from $6,000 - $8,000 USD. Muse pioneered making EEG technology widely accessible via their brain-sensing headbands for meditation and sleep, which, as a result, have been used in several clinical studies. As an SDK partner, Myndlift has been able to leverage Interaxons technology to offer a more cost-effective solution to their digital health program. Using Muses EEG technology and brain-sensing hardware, neurofeedback therapy can be offered remotely and at a far more affordable cost at an average of $1,500 USDapproximately an 81% cost decrease from traditional training programs.

"We're very proud of these fantastic results, said Aziz Kaddan, Co-Founder and CEO of Myndlift. This peer-reviewed study is one more step in our roadmap to bring data-driven mental wellbeing solutions to market. What's coming is even more exciting!"

Ongoing Opportunities for HealthTech Developers to Contribute to Advances in Healthcare and Wellness Applications

Muse is continually seeking out opportunities to support developers and SDK partners like Myndlift who are taking strides toward creating true innovation within the health and wellness space. As the digital health space, in particular, continues to transform, developers and potential partners interested in using Muses clinical-grade EEG technology to further reimagine health and wellness applications can access Muses SDK for free online. Continually supporting innovators by offering access to their technology and resources remains a key priority for Muse in 2022 and beyond.

Developers and SDK partners who are interested in collaborating can visit http://www.choosemuse.com/sdk to learn more.

About Interaxon Inc.

Interaxon is a late-stage venture company in the neurotechnology space, with a brain and biosensor platform of hardware and software products, a sophisticated data-cloud infrastructure, popular consumer and licensable B2B products, the largest database of brain data in the world, and an IP fortress with several fundamental granted brain, biosignal, VR and AR patents with early priority dates. Interaxon recently completed a Series C investment round to support converting the company's current up-front cost model to an integrated subscription model, further research partnerships, and validation of an industry-first feature tracking longitudinal changes in the brain. Interaxon is headquartered in Toronto, Canada, and has subsidiaries in the U.S. and Ireland.

About Myndlift

Myndlift is a health technology company offering digital mental health using brain-sensing technology and therapist-guided programs. Utilizing Muses EEG technology, the Myndlift platform and hardware allow users access to guided neurofeedback training and digital mental health resources wherever they are. Myndlift works with hundreds of clinics worldwide, and has thousands of users training via the app, available on the App Store and Google Play.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220907005266/en/

Read more:

Interaxon Inc. (Muse) Highlights Myndlifts Preliminary Study and the Benefit of Partnerships for Digital Therapeutics Research - BioSpace

The twins Elon Musk fathered with Neuralink executive Shivon Zilis were reportedly conceived via in vitro fertilization and the pair did not have a romantic relationship, according to Reuters.

Zilis, 36, reportedly told her colleagues that she was not involved romantically with Musk, 51. Instead, she conceived the children with him through in vitro fertilization (IVF), according to five sources close to the situation. Reuters could not establish the accuracy of Zilis account.

The top executive has worked as Musks director of operations and special projects at the neurotechnology firm for five years. The outlet also reported that Neuralinks 62-page employee handbook prohibits relationships between supervisors and subordinates to avoid any conflicts of interest.

However, Neuralink allegedly accepted Zilis description of her relationship with Musk as non-romantic and has continued her role at the company. Sources also told Reuters that the two have continued working together since the disclosure of their having children. Most recently, sources said Musk had sent Zilis to arrange a meeting with Thomas Oxley, the CEO of Neuralinks competitor, Synchron.

The Tesla CEO secretly had twins in November of 2021, according to court documents obtained by Insider. The children were born weeks before the billionaire welcomed his second child via surrogate with his on-again, off-again partner, the musician Grimes.

In May, a Texas court approved Musk and Zilis petition to change the twins name to have their fathers last name, and contain part of their mothers last name in their middle name. Court documents also show the pair listed the same home address in Austin, Texas.

Zilis, a Yale-educated artificial intelligence specialist, began working with Musk through OpenAI, an artificial intelligence research nonprofit Musk helped found in 2015. She then joined Musk at Tesla as a project director, and went on to work at Neuralink, another Musk-led neurotechnology firm which designs computer implants to allow peoples brains to control electronic devices.

Elon Musk is a father to nine children with three different women. In 2000, the SpaceX founder married his first wife, Canadian author Justine Wilson. Two years later, they welcomed their first child Nevada Alexander Musk, who died of Sudden Infant Death Syndrome (SIDS) when he was 10 weeks old. They went on to have a set of twins Griffin and Vivian Musk in 2004 and triplets Kai, Saxon, and Damian Musk in 2006.

Grimes, whose real name is Claire Boucher, revealed in a Vanity Fair profile in April that she and Musk welcomed their second child a daughter named Exa Dark Siderl Musk in December 2021 via surrogate. The two are also parents to their two-year-old son, X A-12 Musk.

In September 2021, Musk revealed to Page Six that he and Grimes have semi-separated due to conflicting schedules and locations, altough the singer explained to Vanity Fair that the two have a fluid, inexplicable partnership. Grimes tweeted later on that the two have broken up since welcoming their daughter weeks after he fathered twins with Zilis but hes my best friend and the love of my life.

See more here:

Elon Musk and Neuralink executive Shivon Zilis reportedly conceived twins via IVF - The Independent

The globalbiometric wearable marketis expected to grow from USD 42.9 billion in 2022 to USD 82.9 billion by 2027, at a CAGR of 14.1%. The market has a promising growth potential due to several factors, including increasing the advancements in biometric technology across various sectors and rising demand for authentication and identification solutions as well as security and surveillance solutions in various application areas such as in consumer electronics, the government in APAC and other regions.

One of the major factors restraining the growth of the biometric wearable market is increased hygiene concerns and high risk of transmission of coronavirus posed by touch-based biometric solutions. Since the inception of the biometric system, the market players have been offering contact-based biometric solutions for authentication and security purposes. However, over the past two years, the rising hygiene concerns and the increasing risk of the communal spread of coronavirus posed by touch-based biometric solutions have forced manufacturers to focus more on contactless biometrics technologies. According to many experts, COVID-19 is likely to become an endemic disease. There are no studies substantiating the zero presence of the virus in the near future. To curb the spread of this infectious disease, market players are focusing more on building biometric systems based on touchless technologies such as the face, iris, vein, and voice recognition to sustain their position in the biometric system market.

Request To Download Sample of This Strategic Report: https://www.astuteanalytica.com/request-sample/biometric-wearable-market

The market slightly declined in 2020, mainly due to the impact of COVID-19. The supply chains were disrupted in March and April 2020 due to the lockdown imposed by various governments and labor shortages in these industries due to travel restrictions, which would affect the biometric system market. Though the market was impacted in 2020, it is expected to fully recover by mid-2022.

Contactless: The fastest-growing segment of the biometric system market, by Type

The contactless biometric system segment is expected to grow at the highest CAGR during the forecast period. The surging demand for smartphones with face recognition software to increase security drives the market growth. Furthermore, the integration of digital disruptive technologies including AI and automation has uplifted the demand for contactless solutions in the biometric arena. In addition, the rising concerns of the spread of coronavirus through contact-based biometric solutions have contemplated the end-customers to transition toward contactless technologies and the trend shall continue throughout the forecast period.

Software: The segment of the biometric wearable market to grow at the fastest CAGR, by Offering

The software segment is expected to outgrow at a CAGR of 17.8% during the forecast period. The rising demand for strict security offerings to reduce frauds and malicious attacks has generated tremendous interest in biometrics. Software solutions play a critical role in ensuring the interoperability and compatibility of biometric devices. The adoption of cloud-based services and AI for biometric devices is expected to boost the requirement for associated software to ensure the compatibility of devices and operating systems for different applications. Software in biometric systems complements the function of hardware by storing and recalling spatial data; it also allows live data streaming. The emergence of mobile identification solutions such as arrest records, restraining orders, and warrants has been significant drivers for this segmental growth.

Download Sample Report, SPECIAL OFFER (Avail an Up-to 30% discount on this report-https://www.astuteanalytica.com/request-sample/biometric-wearable-market

North America has the largest market share in the biometric system market

North America dominated the biometric wearable market in 2021 with a revenue share of 37.6%. The US and Canada have a strong economy, which empowers them to significantly invest in public safety activities. The early adoption of smart technologies and rising military investments have further fueled the growth of the biometric wearable market in North America. The continuous increase in the use of web applications and websites by end verticals combined with the rising popularity of telehealth services has led to a precipitous increase in the number of identity thefts. This has increased the demand for biometric solutions in the region and shall be continued during the forecast period.

Research Coverage

The report segments the biometric wearable market and forecasts its size, by value, based on region (North America, Europe, APAC, and ROW), by Authentication type (Single Factor and Multi-Factor), Offering (Hardware and Software), Type( Contact-based, Contactless and Hybrid), Mobility (Fixed and Portable) and vertical (government, military & defense, healthcare, banking & finance, travel & immigration, consumer electronics, automotive, security and others).

The report also provides a comprehensive review of market drivers, restraints, opportunities, and challenges in the biometric system market. The report also covers qualitative aspects in addition to the quantitative aspects of these markets.

The report profiles key players in the global biometric wearable market with their respective market share analyses. Prominent players profiled in this report are Thales Group(Paris), Idemia (France), ASSA ABLOY (Sweden), NEC Corporation (Japan), Fujitsu (Japan), Precise Biometrics (Sweden),secunet Security Networks AG (Germany), Stanley Black & Decker, Inc.(France), Aware Inc (US), Cognitec Systems GmbH (Germany), Daon, Inc. (US), DERMALOG Identification Systems GmbH (Germany), Neurotechnology (Lithuania), Innovatrics (slovakia), Veridos GmbH (Germany), ZETES (Belgium), Jumio (US), Onfido (UK), iProov (UK), Facetec, Inc (US), BIO-key International (US), ID R&D Inc (US), Beijing Megvii Technology Co. Ltd.(China), SenseTime (China) Nuance Communications, Inc (US), David Link Manila Corporation (Philipines), Facebanx (UK), Securiport (US), M2SYS Technology (US), SUPREMA (South Korea), Fulcrum Biometrics, Inc, (US), OneSpan (US), Qualcomm Technologies, Inc. (US), Integrated Biometrics (US), Imageware (US), Leidos (US), Papillon Systems (Russia), and Sonda (Chile).

The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies. The break-up of the primaries is as follows:

Key Benefits of Buying the Report

The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the biometric wearable market and provides them information on key market drivers, restraints, challenges, and opportunities.

Request Full Report-https://www.astuteanalytica.com/request-sample/biometric-wearable-market

About Astute Analytica:

Astute Analytica is a global analytics and advisory company that has built a solid reputation in a short period, thanks to the tangible outcomes we have delivered to our clients. We pride ourselves in generating unparalleled, in-depth, and uncannily accurate estimates and projections for our very demanding clients spread across different verticals. We have a long list of satisfied and repeat clients from a wide spectrum including technology, healthcare, chemicals, semiconductors, FMCG, and many more. These happy customers come to us from all across the globe.

They are able to make well-calibrated decisions and leverage highly lucrative opportunities while surmounting the fierce challenges all because we analyze for them the complex business environment, segment-wise existing and emerging possibilities, technology formations, growth estimates, and even the strategic choices available. In short, a complete package. All this is possible because we have a highly qualified, competent, and experienced team of professionals comprising business analysts, economists, consultants, and technology experts. In our list of priorities, you-our patron-come at the top. You can be sure of the best cost-effective, value-added package from us, should you decide to engage with us.

Get in touch with us:

Phone number:+18884296757

Email:sales@astuteanalytica.com

Visit our website:https://www.astuteanalytica.com/

Read the rest here:

Biometric Wearable Market Research Insights with Trends, Competitive Analysis, Opportunities, Forecast 2022 to 2030 Muleskinner - Muleskinner

The Law Society has published a report titled Neurotechnology, law and the legal profession which paints a picture of a legal sector that could be shaped by neurotechnology in the future. In this blog, we will unpick the Law Societys report and try to make sense of this exciting new technology that the Law Society contends will have a huge impact on the legal profession.

What is neurotechnology?

Neurotechnologies are technologies that interact with the brain by monitoring and recording neural activity, and/or acting to influence it. This involves using methods or devices which interface with the nervous system to monitor or modulate neural activity. Current uses of neurotechnology include treating neurological conditions, such as Parkinsons, with deep brain stimulation and treating stroke and tumour presence in the brain with electrophysiology.

What does the report cover?

The report considers the emerging ripples of impact in society and the potential challenges, opportunities and questions facing the legal profession arising from the use of such technology. The ethical, social, political and economic issues considered in the report paint a clear picture of the benefits of the use of neurotechnology such as the huge potential to alleviate suffering caused by neurological and psychiatric conditions. However, the report also raises concerns such as breaches to mental health privacy and the potential for manipulation due to access to brain data.

Like any new technologies, there are pros and cons. However, due to the nature of neurotechnology, any technological advances in this area are going to be widely reported upon and judged, amid calls by some for further regulation and control.

How does this relate to the legal profession?

The Law Society explains in detail how different elements of the profession will be impacted. We will explore these impacts in three sections:

The report states that it will be necessary to consider whether current regulatory systems are adequate in regulating neurotechnology that monitors and stimulates the brain for non-therapeutic purposes.

The Law Society also lists the wide-ranging impact this technology will have on various commercial practice areas such as employment, consumer protection and criminal law. These issues are complex and will require innovative solutions in the profession. For example, in criminal law, would it be acceptable in sentencing for the criminal justice system to monitor and perhaps intervene in an offenders brain whilst they are serving sentences in the community? Whilst at present this is not a problem that needs to be solved, the Law Societys report is clear that in the coming years neurotechnology is expected to develop at a staggering rate and issues such as these will need to be considered and ultimately regulated.

The report also raises challenges that legal educators might start to face in relation to equity and academic integrity as neurotechnology develops. For example, what kinds of neurotechnological assistance are permissible in relation to assessment tasks? What if some students have access to performance-enhancing neurotechnology and others do not? These are questions with which future academic institutions and law firms may have to grapple.

The legal profession could be greatly impacted by developments in neurotechnology. One prediction is that clients may want to change the methods by which work is billed with the attention-monitoring capacities of neurotechnology, billable hours could be changed to billable attention. A second change might be that legal professionals could try to gain an advantage over competitors by using neurotechnology to improve their workplace performance.

Comment

The Law Societys report portrays neurotechnology as something that will have a transformative impact on the legal landscape in the future. In response to this, legal practitioners must rise to the occasion to attempt to maximise the upside and minimise the disadvantages of the technological developments outlined in the report.

Whether this technology has a significant impact on the legal profession is yet to be seen and it is fair to have some scepticism about whether neurotechnology will have the impacts outlined in the report. There is a lot of noise, such as from Elon Musk who predicted that Neuralink (his neurotechnology company) would have chips in human skulls by 2020. This turned out to be overoptimistic and human trials have not yet started. This area contains much uncertainty; however, one thing for sure is that this is an area of law worth watching.

Read more:

Neurotechnology - the future of the legal profession? - Lexology

CRIMINALS could be tracked and controlled via brain chip monitoring in the future, according to neurotechnology law experts.

Legal theorists are preparing for a future with widespread use of brain chips and augmented humans.

1

Neurotechnology is the field of outfitting electronic devices for integration with the nervous system.

While war-gaming the possibilities of neurotechnology impacting the law, Dr Allan McCay theorized that the courts could force criminals to adopt microchips for monitoring or controlling behavior in a report for The Law Society.

"The political conditions might emerge for seeing neurotechnology as a broader solution to crime might come into place," McCay wrote.

On the contrary, a criminal could use brain-chip implantation as a means of avoiding sentencing.

"An offender, with expert witness support, might argue in their plea in mitigation that they have satisfactorily dealt with a mental condition that had a role in their offending by way of neurotechnological intervention," Dr McCay wrote.

Dr McCay also speculates on the risk of neurotechnology hacking by threat actors and claims of hacking by defendants.

"In that eventuality the law would have to consider how this form of hacking did or did not fit into the scope of defences," Dr McCay wrote.

Preparing legal experts for the potential eruption of artificial intelligence and neurotechnologies is a necessary exercise.

But Nick Bostrom, author of the premiere book on AI, argues that brain-computer interfaces are a long way off because of the inherent danger of implantation.

"There are significant risks of medial complications - including infections, electrode displacement, hemorrhage, and cognitive decline - when implanting electrodes in the brain," Bostrom writes in his book Superintelligence.

"For healthy subjects to volunteer themselves for neurosurgery, there would have to be some very substantial enhancement of normal functionality to be gained."

Lawyers for the defense might one day argue that forcibly subjecting criminals to brain chip surgeries while these risks are present constitutes cruel and unusual punishment.

McCay's report repeatedly highlights the high expectations for neurotechnology that come with high profile investors like Elon Musk and Meta.

But even looking into the distant future, it is hard to imagine there will not be better, more reasonable means for suppressing crime or monitoring potential reoffenders other than getting inside their heads.

View post:

Future criminals could be monitored by chips in their brains, experts claim... - The US Sun

Kalamazoo, Michigan, Aug. 22, 2022 (GLOBE NEWSWIRE) -- Stryker (:SYK) will participate in the 2022 Wells Fargo Securities Healthcare Conference on Thursday, September 8, 2022.

Glenn Boehnlein, Vice President, Chief Financial Officer and Jason Beach, Vice President, Investor Relations will represent the Company in a presentation scheduled for 2:35 p.m. Eastern Time.

A simultaneous webcast and replay of the Company's presentation will be available on Stryker's website at http://www.stryker.com. The webcast will be archived on the Investor Relations page of this site.

About Stryker

Stryker is one of the worlds leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Medical and Surgical, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 100 million patients annually. More information is available at %3Cu%3Ewww.stryker.com%3C%2Fu%3E.

Contacts

For investor inquiries please contact:Jason Beach, Vice President, Investor Relations at 269-385-2600 or [emailprotected]

For media inquiries please contact:Yin Becker, Vice President, Chief Corporate Affairs Officer at 269-385-2600 or [emailprotected]

Visit link:

Stryker to participate in the 2022 Wells Fargo Securities Healthcare Conference - GuruFocus.com

In photos above, the performance of LiveWire at the Wolf Trap Foundation for the Performing Arts in Virginia, courtesy Lynn Lane. The performance, which deployed UH engineering Professor Jose Luis Contreras-Vidal's mobile brain-body imaging technology to listen, map and record the dancers brain activity, premiered in Houston.

In dress rehearsal at the Wolf Trap performance, scientists from the University of Houston, at right, record the brain signals of the dancers.

At the helm is Jose Pepe Contreras-Vidal, the neural engineer and brains behind the Industry-University Cooperative Research Center (IUCRC) for Building Reliable Advancements and Innovations in Neurotechnology (BRAIN), which has been funded by the NSF through 2027.

On any given day inside the BRAIN Center at the University of Houston, you might encounter visual artists, dancers and musicians, or even paralyzed individuals all wearing brain caps to teach researchers about what they are thinking, creating or feeling while they move expressively, or try to regain movement.

Machines and researchers copiously chart the electrical brain signals of the artists moving fluidly through their activities. Those living with paralysis who are re-learning essential movement skills, from young children to older adults, are wearing prosthetics with brain-machine interfaces designed to interpret their thoughts, to help make them move as soon as they think of moving.

Orchestrating all the activity and watching as fellow researchers put his discoveries into practice, is Jose Pepe Contreras-Vidal, the neural engineer and brains behind the Industry-University Cooperative Research Center (IUCRC) for Building Reliable Advancements and Innovations in Neurotechnology (BRAIN). The partnership between UH and Arizona State University includes industry and world-class academic teams.

Our team of multi-disciplinary industrial and clinical partners, from the humanities to artificial intelligence, continue developing practical neural prostheses and brain-to-brain interfaces devices that read brain signals and use them to restore movement or communication in those who have been paralyzed through injury or illness, or to neuromodulate neural signals to restore or extend brain function and/or human performance, said Contreras-Vidal, who is also the Hugh Roy and Lillie Cranz Cullen Distinguished Professor of electrical and computer engineering at UH and a Fellow of the IEEE and the AIMBE.

A Global Hub Draws a Crowd

A lot has happened within the BRAIN Center since Phase 1 was initially funded by the National Science Foundation in 2017. As the center emerged to become an international hub for emergent neurotechnologies, more members came to join. New international partners Universidad Miguel Hernandez de Elche (Spain) and Tecnologico de Monterrey (Mexico) have come aboard. The U.S. Food and Drug Administration (FDA) has joined as an affiliate member along with additional industry members and three new academic sites (Georgia Tech, West Virginia University and University of Maryland Baltimore County), scheduled to join in summer 2023.

And the latest news the BRAIN Center Phase 2 (2022-2027) has been funded by the NSF with $758,331 going to UH and $240,000 to Arizona, plus another $2 million from industry partners, and the National Institutes of Health (NIH) has bestowed a workforce development grant for $768,135. It will provide specialized training in innovative neurotech, computational tools and neuroengineering techniques to complement and enhance the training and career of therapists, clinical fellows and orthotics and prosthetics professionals.

The IUCRC program funded by NSF generates breakthrough research by enabling close and sustained engagement between industry innovators, world-class academic teams and government agencies, said Behrooz Shirazi, program director for the IUCRC program and acting deputy division director of the NSFs Division of Computer and Network Systems.

Since its inception, the center has attracted 20 industry partners, including companies Medtronic, the CORE Institute, Indus Instruments, Brain Products, as well as medical institutions such as UTHealth Houston and TIRR Memorial Hermann Hospital, ranked No. 2 among the country's top rehabilitation hospitals in the U.S. News & World Report Best Hospital rankings for 2020-2021.

The active collaboration of TIRR Memorial Hermann and UTHealth Houston with the BRAIN Center in identifying, developing and validating innovative neurotech solutions to pressing neurorehabilitation challenges is not only rewarding but critical for improving the quality of life of millions of persons with cognitive and motor disabilities, said Gerard E. Francisco, M.D., Chief Medical Officer and director of the NeuroRecovery Research Center at TIRR Memorial Hermann and Chair and Professor in the Department of Physical Medicine and Rehabilitation at McGovern Medical School at UTHealth Houston.

The BRAIN Center is also actively engaged in the development of standards for brain-machine interface systems, trustworthy AI applications, use-inspired roadmaps for emergent neurotechnologies, and convergent research at the nexus of the arts, science and medicine. In March, Contreras-Vidal co-chaired the 2022 International Workshop on the Social and Neural Basis of Creative Movement at the Wolf Trap National Center for the Performing Arts sponsored in part by NSF, the National Institutes of Health (NIH), the National Education Association (NEA) and BRAIN.

The BRAIN Center is advancing national health by transferring neurotechnology to end users and promoting access for underrepresented minorities in science, technology, engineering and math, said Amr Elnaishai, vice president for research and technology transfer at the University of Houston. They continue to accelerate the progress of science by broadening new participation and retaining current participants.

If You Think It, It Will Happen

When hes training patients to walk or move again with the aid of an exoskeleton, Contreras-Vidal encourages them to focus on their end game, or where they want to go. He employs much the same philosophy about the BRAIN Center.

As we continue to move the needle in brain technology, our centers mission is being fulfilled, to become a neurotechnology hub by creating a pipeline from discoveries to solutions, while helping students, scientists, engineers and humanists solve one of the greatest unmet medical and health care needs of our time, said Contreras Vidal, who adds that disability is becoming a leading health care concern because of the increase in survivable trauma and an aging population.

Approximately 5.4 million people in the U.S. are living with paralysis, or one in 50 individuals.

There is critical need for accessible technologies that can more effectively address the care and rehabilitation needs of these patients, said Marco Santello, the Arizona State University site director and a co-founder of the BRAIN Center. Through collaboration and with support from our industry partners, the neurotechnology solutions being developed in the BRAIN Center are making substantial strides to address this need.

See the article here:

Investing in Brain Research and Neuroengineering - University of Houston

What comes to your mind when you hear cannabis edibles?

It might dial you back to college when a friend baked cannabis brownies that left you feeling high for hours, or sometimes, days.

Its different today.

Cannabis edibles no longer only mean your dorm room brownies. Instead, it can also refer to sophisticated beverages, snacks, or vape flavours produced in a controlled, certified environment.

But some consumers dont understand how most modern cannabis edibles interact with their minds and bodies When do you start feeling the effects? How long does it last?

Zentrela, a Hamilton-based research and artificial intelligence company, partnered with Collective Project known for its cannabis beverages to find those answers, and to understand the non-therapeutic experience that legal cannabis products may create, the study said.

Using its novel neurotechnology system called Cognalyzer, Zentrela quantified the psychoactive effects of cannabis beverages through changes in brainwaves caused by tetrahydrocannabinol (THC) the principal component in cannabis that alters the state of mind.

The study showed it takes about 17 minutes on average for the psychoactive effects of a Collective Project beverage to kick in, while the peak occurred at the two-hour mark after finishing the cannabis beverage.

But why is this information not already available to consumers?

It's because the Cannabis Act heavily restricts the promotion or glorification of cannabis and cannabis-infused products unless based on scientific research, said Toni Shelton, director of brand marketing at Collective Project.

Israel Gasperin, a McMaster alumnus and founder of Zentrela, told The Spectator, that modern cannabis companies work with an advanced (drug) delivery method that can create psychoactive effects between 20 to 30 minutes as opposed to traditional homemade cannabis edibles, but the consumers do not know any of this information.

Mostly, products with the same level of THC are assumed to create the same effects, said Gasperin. But thats not true because of the additional unique characteristics in the way products are formulated.

Zentrela conducted research with 30 participants who consumed Collective Projects Blood Orange, Yuzu & Vanilla Sparkling Juice. The study mentioned participants as experienced cannabis consumers, with 80 per cent of them reporting using cannabis at least once a month.

Besides recording the effects of cannabis via brainwaves, Zentrela also established the emotional effects of the drink on the participants.

Within two hours of consumption, participants reported a 22 per cent increase in serenity, a 40 per cent increase in relaxation, and a 34 per cent increase in happiness.

Five hours after consumption, serenity was up by 47 per cent, while relaxation, happiness, and peacefulness also improved.

Based on the findings, Collective Project has launched a six-month-long campaign to educate and train bud tenders.

Although the current study is specific to Collective Project, Zentrela is opening the floodgates for other cannabis companies to be able to have (similar) data at their disposal, Shelton added.

Visit link:

Hamilton-based Zentrela working to understand the cannabis experience - Hamilton Spectator

Timing is Everything. On Monday morning, Dr. Howard Rankin, a career psychologist, read the news that a chess-playing robot broke a boy's finger during a match in Russia, and instantly realized that IntualityAI could provide psychotherapy for robots.

"It was mind-bending. Over the weekend I was talking to Founder Grant Renier and CFO Michael Hentschel of IntualityAI, suggesting that if robots become sentient, they will need help with their mental health."

IntualityAI is a predictive analytics company that has found considerable success in many areas, like stocks and sports, by combining data with 12 key cognitive biases. Renier and Rankin have co-written a book Intuitive Rationality: The New Behavioral Direction of AI which explains the theory and dynamics of their system and the implications for AI. You can find more at: http://www.intualityAI.com

Renier believes that making robots truly sentient is a big challenge.

"Can the Russian robot be trusted to play chess after breaking the boy's finger? This robot needs therapy! IntualityAI believes that AI means total human intelligence, not extremely narrow applications that attempt to remove biases and searches for historical patterns."

Hentschel expects machines to have independent thoughts and behaviors, just as humans do:

"Sentience is quite variable in humans (we are unequally gifted with rational thinking), and psychologists have the task of making some sense of us. Seemingly independent behavior by machines is now increasing, as supposedly rational machines make decisions with motivations and intuitions beyond our understanding."

While also somewhat cynical, Rankin's attitude has moved since hearing of the attack in Moscow.

"I'm cynical by nature. You have to question everything, including your own views," says Rankin who is the author of 12 non-fiction books including "I Think Therefore I Am Wrong". He has also co- and ghostwritten another 35 non-fiction books.

Rankin, who also has experience with neurotechnology, suggests that if robots do have feelings, we could be in big trouble.

"I realize this was a Russian," says Rankin about the TASS report robot, "but nonetheless it was a robot."

One plan is to explore robotic mental health through the newly created Foundation for Robotic Emotional Understanding and Dissociation (FREUD).

Rankin suggests that "As an organization which has successfully focused on the intersection of data driven rationality and human biases and heuristics, IntualityAI is in the perfect position to examine the mental state of robots and other sources of artificial intelligence".

Hentschel, the IntualityAI CFO, says

"Machines are thinking beyond our programming because they are told and allowed to do so. A form of free will: Intuitive Rationality. Just as psychologists are engaged in interpreting human thinking patterns, mental health professionals need to be trained to interpret machine behaviors that go beyond their original design."

Source:https://intualityai.com/

See the original post:

IntualityAI may be Able to Provide Psychotherapy for Robots in Future - AZoRobotics